On February 26, 2025, Renovaro Inc. entered into a merger agreement with Biosymetrics, where Biosymetrics will become a wholly owned subsidiary and issue 15 million shares of common stock to its stockholders. The merger is subject to various closing conditions, including stockholder approval and regulatory compliance.